Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “Pfizer”
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Peripheral T-cell Lymphoma
United States, France, Italy, Spain, United Kingdom
Sponsor: University of Washington
Acute Myeloid Leukemia
United States
- A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia AreataRecruiting
Sponsor: Pfizer
Alopecia Areata
United States, Canada, China, Czechia, Japan +6 more
- A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple MyelomaActive Not Recruiting
Sponsor: Pfizer
Multiple Myeloma
United States, Israel
- A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical StudyActive Not Recruiting
Sponsor: Astellas Pharma Global Development, Inc.
Prostate Cancer
United States, Argentina, Australia, Austria, Belgium +33 more
Sponsor: Mats Heyman
Leukemia, Acute Lymphoblastic
Belgium, Denmark, Estonia, Finland, France +10 more
Sponsor: Hoffmann-La Roche
Metastatic Breast Cancer
United States, Australia, France, Germany, Israel +4 more
Sponsor: Pfizer
COVID-19
South Korea
- A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare TumoursActive Not Recruiting
Sponsor: Canadian Cancer Trials Group
Advanced Rare Tumours
Canada
Sponsor: SCRI Development Innovations, LLC
Multiple Myeloma (MM) · Multiple Myeloma Refractory · Multiple Myeloma in Relapse · Multiple Myeloma
United States
Sponsor: Pfizer
Diabetes Mellitus, Type 2
Belgium, Finland, France, Germany, Netherlands +5 more
Sponsor: Pfizer
Hemophilia B
United States, Australia, Canada, Turkey (Türkiye)
- A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer (MEVPRO-1).Active Not Recruiting
Sponsor: Pfizer
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
United States, Argentina, Australia, Brazil, Canada +18 more
- This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes MellitusCompleted
Sponsor: Pfizer
Diabetes Mellitus, Type 2
United States, Puerto Rico
Sponsor: Intergroupe Francophone du Myelome
Multiple Myeloma, Newly Diagnosed
France
Sponsor: Pfizer
Lupus Erythematosus, Systemic · Lupus Erythematosus, Cutaneous
United States, Canada, Greece, Spain
- A Study of Inotuzumab and Blinatumomab in People With B-cell Acute Lymphoblastic LeukemiaNot Yet Recruiting
Sponsor: Memorial Sloan Kettering Cancer Center
B-cell Acute Lymphoblastic Leukemia · B-Cell Acute Lymphoblastic Leukemia, Adult · B-ALL
United States
Sponsor: Pfizer
Pneumococcal Diseases
China
Sponsor: Association of Migraine Disorders
Headache Disorders · Dizziness · Vestibular Diseases · Sinus Disease
United States
Sponsor: Pfizer
Healthy
Belgium
- Utilization and Effectiveness of Ritlecitinib in a Real-World Population With Severe AA in the USCompleted
Sponsor: Pfizer
Alopecia Areata
United States
- A Study to Learn About Study Medicine Lorlatinib, as a First-line Treatment in Chinese Adults With ALK-positive a/mNSCLCActive Not Recruiting
Sponsor: Pfizer
Non-Small Cell Lung Cancer ALK-positive
China
Sponsor: Pfizer
Hemophilia A · Hemophilia B
United States, Argentina, Australia, Austria, Brazil +19 more
Sponsor: Pfizer
Pneumococcal Disease
United States, Australia, Canada
Sponsor: Kyoto University
Amyotrophic Lateral Sclerosis
Japan